Effect of long-term administration of the antidepressant drug milnacipran on serotonergic and noradrenergic neurotransmission in the rat hippocampus

Life Sciences

Volumn 81, Issue 2, 2007, Pages 166-176

  Weiss, Michel ^a,b   Blier, Pierre ^a   Montigny, Claude de ^a  

^a MCGILL UNIVERSITY   (Canada)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

CA3 pyramidal cells; Hippocampus; Microiontophoresis; Milnacipran; NE and 5 HT transmission

Indexed keywords

5 CARBAMOYLTRYPTAMINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; CHLORAL HYDRATE; MILNACIPRAN; SEROTONIN; SEROTONIN 1A RECEPTOR;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; ELECTROSTIMULATION; HIPPOCAMPUS; LOCUS CERULEUS; MALE; NERVE CONDUCTION; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PYRAMIDAL NERVE CELL; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM;

ANIMALS; ANTIDEPRESSIVE AGENTS; CYCLOPROPANES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; HIPPOCAMPUS; IONTOPHORESIS; MALE; NOREPINEPHRINE; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC; RECEPTORS, PRESYNAPTIC; RECEPTORS, SEROTONIN; SEROTONIN; SYNAPTIC TRANSMISSION;

RATTUS;

EID: 34250358750     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.04.039     Document Type: Article

References (40)

1. Anderson C.D., Pasquier D.A., Forbes W.B., and Morgane P.J. Locus coeruleus-to-dorsal raphe input examined by electrophysiological and morphological methods. Brain Research Bulletin 2 3 (1977) 209-221
2. Bandoh T., Hayashi M., Ino K., Takada S., Ushizawa D., and Hoshi K. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters. European Neuropsychopharmacology 14 (2004) 471-478
3. Baraban J.M., and Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19 4 (1980) 355-363
4. Baraban J.M., and Aghajanian G.K. Suppression of serotonergic neuronal firing by alpha-adrenoceptor antagonists: evidence against GABA mediation. European Journal of Pharmacology 66 4 (1980) 287-294
5. Blier P., Chaput Y., and de Montigny C. Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology 337 3 (1988) 246-254
6. Blier P., Galzin A.M., and Langer S.Z. Interaction between serotonin uptake inhibitors and alpha-2 adrenergic heteroreceptors in the rat hypothalamus. Journal of Pharmacology and Experimental Therapeutics 254 1 (1990) 236-244
7. Blier P., Lista A., and de Montigny C. Differential properties of pre-and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins. Journal of Pharmacology and Experimental Therapeutics 265 1 (1993) 16-23
8. Blier P., Mongeau R., Weiss M., and de Montigny C. Modulation of serotonin neurotransmission by presynaptic alpha-2-adrenergic receptors: a target for antidepressant pharmacotherapy?. In: Mendlewicz J., Brunello N., Langer S.Z., and Racagny G. (Eds). New Pharmacological Approaches to the Therapy of Depressive Disorders (1993), Karger, Basel 74-82
9. Cedarbaum J.M., and Aghajanian G.K. Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the alpha-antagonist piperoxane. Brain Research 112 2 (1976) 413-419
10. Chaput Y., and de Montigny C. Effects of the 5-hydroxytryptamine receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system. Journal of Pharmacology and Experimental Therapeutics 246 1 (1988) 359-370
11. Chaput Y., Blier P., and de Montigny C. In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. Journal of Neuroscience 6 10 (1986) 2796-2801
12. Chaput Y., de Montigny C., and Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology 333 4 (1986) 342-348
13. Curet O., and de Montigny C. Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine. Brain Research 475 1 (1988) 35-46
14. Curet O., and de Montigny C. Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. II. Receptors mediating the effect of synaptically released norepinephrine. Brain Research 475 1 (1988) 47-57
15. Curet O., and de Montigny C. Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. III. Evidence for the physiological role of terminal alpha 2-adrenergic autoreceptors. Brain Research 499 1 (1989) 18-26
16. Curet O., De Montigny C., and Blier P. Effect of desipramine and amphetamine on noradrenergic neurotransmission: electrophysiological studies in the rat brain. European Journal of Pharmacology 221 1 (1992) 59-70
17. de Montigny C., and Blier P. Electrophysiological evidence for the distinct properties of presynaptic and postsynaptic 5-HT1A receptors: possible clinical relevance. In: Langer S.Z., Mendlewicz J., and Racagni G. (Eds). International Academy of Biomedical Drug Research (1991), Karger, Basel 80-88
18. Frankhuijzen A.L., Wardeh G., Hogenboom F., and Mulder A.H. Alpha 2-adrenoceptor mediated inhibition of the release of radiolabelled 5-hydroxytryptamine and noradrenaline from slices of the dorsal region of the rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology 337 3 (1988) 255-260
19. Hyttel J. Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Progress in Neuropsychopharmacology and Biological Psychiatry 6 3 (1982) 277-295
20. Kasper S., Pletan Y., Solles A., and Tournoux A. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results. International Clinical Psychopharmacology 11 4 (1996) 35-39
21. Lacroix D., Blier P., Curet O., and de Montigny C. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. Journal of Pharmacology and Experimental Therapeutics 257 3 (1991) 1081-1090
22. Lecrubier Y., Pletan Y., Solles A., Tournoux A., and Magne V. Clinical efficacy of milnacipran: placebo-controlled trials. International Clinical Psychopharmacology 11 4 (1996) 29-33
23. Lehmann J., Koenig-Berard E., and Vitou P. The imidazoline-preferring receptor. Life Sciences 45 18 (1989) 1609-1615
24. Lopez-Ibor J., Guelfi J.D., Pletan Y., Tournoux A., and Prost J.F. Milnacipran and selective serotonin reuptake inhibitors in major depression. International Clinical Psychopharmacology 11 4 (1996) 41-46
25. Macher J.P., Sichel J.P., Serre C., Von Frenckell R., Huck J.C., and Demarez J.P. Double-blind placebo-controlled study of milnacipran in hospitalized patients with major depressive disorders. Neuropsychobiology 22 2 (1989) 77-82
26. Maura G., Roccatagliata E., and Raiteri M. Serotonin autoreceptor in rat hippocampus: pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn-Schmiedeberg's Archives of Pharmacology 334 4 (1986) 323-326
27. Mochizuki D., Hokonohara T., Kawasaki K., and Miki N. Repeated administration of milnacipran induces rapid desensitization of somatodendritic 5-HT1A autoreceptors but not postsynaptic 5-HT1A receptors. Journal of Psychopharmacology 16 (2002) 253-260
28. Mongeau R., Blier P., and de Montigny C. In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn-Schmiedeberg's Archives of Pharmacology 347 3 (1993) 266-272
29. Mongeau R., Blier P., and de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Research Reviews 23 3 (1997) 145-195
30. Mongeau R., de Montigny C., and Blier P. Effects of long-term alpha-2 adrenergic antagonists and electroconvulsive treatments on the alpha-2 adrenoceptors modulating serotonin neurotransmission. Journal of Pharmacology and Experimental Therapeutics 269 3 (1994) 1152-1159
31. Mongeau R., de Montigny C., and Blier P. Electrophysiologic evidence for desensitization of alpha 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology 10 1 (1994) 41-51
32. Mongeau R., Weiss M., de Montigny C., and Blier P. Effect of acute, short-and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons. Neuropharmacology 37 7 (1998) 905-918
33. Moret C., Charveron M., Finberg J.P., Couzinier J.P., and Briley M. Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug. Neuropharmacology 24 12 (1985) 1211-1219
34. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. Second edition (1986), Academic press, New York
35. Sakai K., Salvert D., Touret M., and Jouvet M. Afferent connections of the nucleus raphe dorsalis in the cat as visualized by the horseradish peroxidase technique. Brain Research 137 1 (1977) 11-35
36. Scuvee-Moreau J.J., and Svensson T.H. Sensitivity in vivo of central alpha 2- and opiate receptors after chronic treatment with various antidepressants. Journal of Neural Transmission 54 1-2 (1982) 51-63
37. Simmonds M.A. Quantitative evaluation of responses to microiontophoretically applied drugs. Neuropharmacology 13 (1974) 401-406
38. Unnerstall J.R., Fernandez I., and Orensanz L.M. The alpha-adrenergic receptor: radiohistochemical analysis of functional characteristics and biochemical differences. Pharmacology Biochemistry and Behavior 22 5 (1985) 859-874
39. Verge D., Daval G., Patey A., Gozlan H., el Mestikawy S., and Hamon M. Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. European Journal of Pharmacology 113 3 (1985) 463-464
40. von Frenckell R., Ansseau M., Serre C., and Sutet P. Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients. A new approach in dose ranging studies. International Clinical Psychopharmacology 5 1 (1990) 49-56